Charles Schwab
ASPN icon

Charles Schwab’s Aspen Aerogels ASPN Stock Holding History

Charles Schwab’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
556,725
+16,402
+3% +$55.3K ﹤0.01% 2732
2025
Q4 		$1.53M Sell
540,323
-32,265
-6% -$166K ﹤0.01% 2806
2025
Q3 		$3.99M Buy
572,588
+26,745
+5% +$189K ﹤0.01% 2530
2025
Q2 		$3.23M Buy
545,843
+58,112
+12% +$334K ﹤0.01% 2510
2025
Q1 		$3.12M Sell
487,731
-61,978
-11% -$598K ﹤0.01% 2468
2024
Q4 		$6.53M Buy
549,709
+40,279
+8% +$687K ﹤0.01% 2209
2024
Q3 		$14.1M Buy
509,430
+342,253
+205% +$8.56M ﹤0.01% 1877
2024
Q2 		$3.99M Buy
167,177
+23,826
+17% +$559K ﹤0.01% 2437
2024
Q1 		$2.52M Sell
143,351
-3,391
-2% -$50K ﹤0.01% 2529
2023
Q4 		$2.32M Sell
146,742
-2,416
-2% -$24.9K ﹤0.01% 2567
2023
Q3 		$1.28M Buy
149,158
+4,254
+3% +$30.2K ﹤0.01% 2718
2023
Q2 		$1.14M Buy
144,904
+8,070
+6% +$56.2K ﹤0.01% 2719
2023
Q1 		$1.02M Buy
136,834
+43,288
+46% +$430K ﹤0.01% 2723
2022
Q4 		$1.1M Buy
93,546
+14,456
+18% +$165K ﹤0.01% 2745
2022
Q3 		$730K Buy
79,090
+7,482
+10% +$90.6K ﹤0.01% 2892
2022
Q2 		$708K Buy
71,608
+13,016
+22% +$263K ﹤0.01% 2926
2022
Q1 		$2.02M Buy
58,592
+970
+2% +$31.5K ﹤0.01% 2645
2021
Q4 		$2.87M Buy
57,622
+1,296
+2% +$68.3K ﹤0.01% 2581
2021
Q3 		$2.59M Sell
56,326
-1,471
-3% -$58.3K ﹤0.01% 2639
2021
Q2 		$1.73M Buy
57,797
+3,565
+7% +$72.7K ﹤0.01% 2761
2021
Q1 		$1.1M Sell
54,232
-23,573
-30% -$497K ﹤0.01% 2822
2020
Q4 		$1.3M Buy
77,805
+6,678
+9% +$87.8K ﹤0.01% 2702
2020
Q3 		$779K Buy
71,127
+20,800
+41% +$165K ﹤0.01% 2735
2020
Q2 		$332K Buy
+50,327
New +$323K ﹤0.01% 2995
2019
Q3 		– Sell
-14,261
Closed -$102K – 3179
2019
Q2 		$102K Hold
14,261
– – ﹤0.01% 3127
2019
Q1 		$37K Buy
+14,261
New +$42.4K ﹤0.01% 3180
2015
Q2 		– Sell
-12,000
Closed -$88K – 3094
2015
Q1 		$88K Hold
12,000
– – ﹤0.01% 3044
2014
Q4 		$96K Buy
+12,000
New +$102K ﹤0.01% 3067

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Charles Schwab's ASPN Position: Q1 2026 in Review

Charles Schwab increased its Aspen Aerogels (ASPN) stake by 3% in Q1 2026, buying an estimated $55.3K and bringing the position to 556,725 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Charles Schwab first reported a position in ASPN in Q4 2014 and has held it in 28 quarters since. The position peaked at $14.1M in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Charles Schwab held 556,725 shares of Aspen Aerogels worth $1.9M as of Q1 2026.
  • Charles Schwab bought 16,402 Aspen Aerogels shares in Q1 2026, an estimated $55.3K.
  • Aspen Aerogels made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #2732 holding.
  • Charles Schwab first reported a position in Aspen Aerogels in Q4 2014 and has held it in 28 quarters since.
  • Charles Schwab's Aspen Aerogels position peaked at $14.1M in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.